14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Poster Sessions Sunday, May 2, 2004<br />
P498 In vitro activity <strong>of</strong> antimicrobial drugs against<br />
Brucella melitensis strains in an endemic area<br />
N. Elaldi, M.Z. Bakici, M. Bakir, I. Dokmetas,<br />
M. Sencan (Sivas, TR)<br />
P499 Thermophilic Campylobacter resistance to<br />
five antimicrobial drugs<br />
B. Miljkovic-Selimovic, M. Mraovic, B. Potkonjak,<br />
T. Babic, B. Kocic, L. Ristic (Nis, Belgrade, CS)<br />
P500 In vitro activity <strong>of</strong> 12 antianaerobic agents<br />
against clinical Bacteroides fragilis group<br />
strains isolated over a 7-month period<br />
L. Alcalá, T. Peláez, N. García-Escribano,<br />
Ó. Pérez-Olaso, J. Martínez-Alarcón, J. Guinea,<br />
E. Bouza (Madrid, E)<br />
P501 The effect <strong>of</strong> sub-inhibitory concentration<br />
(sub-MIC) <strong>of</strong> amikacin <strong>and</strong> cipr<strong>of</strong>loxacin on<br />
the loss <strong>of</strong> capsular antigen K1 by Escherichia<br />
coli strains<br />
D. Wojnicz, A. Cisowska, S. Jankowski<br />
(Wroclaw, PL)<br />
P502 Antibiotic susceptibilities <strong>and</strong> extendedspectrum<br />
beta-lactamase production <strong>of</strong><br />
Enterobacteriaceae from urinary tract<br />
infections<br />
B. Kocic, S. Antic, B. Tiodorovic, T. Babic,<br />
L. Ristic, V. Mladenovic (Nis, CS)<br />
P503 Agreement between disc diffusion <strong>and</strong><br />
E-test methods to assess the carbapenem<br />
susceptibility <strong>of</strong> four Gram-negative<br />
nosocomial pathogens<br />
B. Cakir, S. Unal, O. Uzun (Ankara, TR)<br />
P504 Gram-negative nosocomial pathogens in<br />
Estonian intensive care units (ICUs)<br />
K. Lõivukene, E. Sepp, V. Adamson, Ü. Kall<strong>and</strong>i,<br />
K. Otter, P. Naaber (Tartu, Tallinn, EST)<br />
P505 Effects <strong>of</strong> subminimal inhibitory concentrations<br />
<strong>of</strong> three antimicrobials on the virulence<br />
factors <strong>and</strong> growth <strong>of</strong> Proteus mirabilis<br />
M. Ucar, S. Ozden, Y. Dogan, S. Kirdar, Ö. Yilmaz,<br />
H. Baskin (Izmir, TR)<br />
P506 In vitro susceptibility <strong>of</strong> Pseudomons aeruginosa<br />
isolated in a burn centre in south Iran,<br />
to silversulfadiazine <strong>and</strong> silver nitrate<br />
M. Hayati, A. Japoni, A. Alborzi, M. Kalani<br />
(Shiraz, IR)<br />
P507 Antimicrobial resistance among<br />
Streptococcus pneumoniae <strong>and</strong> Haemophilus<br />
influenzae from Africa <strong>and</strong> the Middle East:<br />
2002/2003 winter season<br />
A. Shibl, J. Daniels, J. Sievers <strong>and</strong> the<br />
SOAR in AME Study Group<br />
12:00–13:00<br />
Antifungal susceptibility studies<br />
P508 Comparative evaluation <strong>of</strong> AFST-EUCAST<br />
method <strong>and</strong> Sensititre YeastOne Colorimetric<br />
antifungal panel with NCCLS reference<br />
method for susceptibility testing <strong>of</strong> C<strong>and</strong>ida<br />
species<br />
M. Yucesoy, C. Ergon (Izmir, TR)<br />
P509 Determination <strong>of</strong> antifungal activity <strong>of</strong><br />
casp<strong>of</strong>ungin using flow cytometry<br />
S. Costa-de-Oliveira, C. Pina-Vaz, C. Tavares,<br />
A. Gonçalves Rodrigues (Porto, P)<br />
P510 Paradoxical casp<strong>of</strong>ungin effect: reduced<br />
activity against C<strong>and</strong>ida albicans at high<br />
concentrations<br />
D.A. Stevens, T.C. White, D.S. Perlin, M. Espiritu,<br />
R. Parmar (San Jose, Seattle, Newark, USA)<br />
P511 Bi<strong>of</strong>ilms <strong>of</strong> C<strong>and</strong>ida albicans on silicon<br />
catheters could be reduced by casp<strong>of</strong>ungin<br />
in vitro<br />
C. Cocuaud, S. Imbert-Bouyer, M.-H. Rodier,<br />
C. Imbert (Poitiers, F)<br />
P512 In vitro activities <strong>of</strong> fluconazole <strong>and</strong><br />
voriconazole against Spanish bloodstream<br />
isolates <strong>of</strong> C<strong>and</strong>ida glabrata <strong>and</strong> C<strong>and</strong>ida<br />
krusei<br />
G. Quindós, L. Sánchez, M. Villar, P. Ahuad,<br />
E. Eraso, J. Hernández (Bilbao, E; Mexico City,<br />
MEX; Buenos Aires, AR; Barakaldo, E)<br />
P513 Comparison <strong>of</strong> the in vitro activity <strong>of</strong><br />
anidulafungin with amphotericin B,<br />
casp<strong>of</strong>ungin, fluconazole, itraconazole <strong>and</strong><br />
voriconazole against a panel <strong>of</strong> 780 yeast<br />
isolates obtained from five <strong>European</strong> centres<br />
E.M. Johnson, B.P. Goldstein, K.G. Davey,<br />
M.A. Fraser (Bristol, UK; Pen, USA)<br />
P514 The efficiency <strong>of</strong> fluconazole <strong>and</strong> amphotericin<br />
B in comparison with echinoc<strong>and</strong>in<br />
micafungin <strong>and</strong> benzothiazole APB in C<strong>and</strong>ida<br />
albicans <strong>and</strong> C<strong>and</strong>ida dubliniensis isolated<br />
from HIV <strong>and</strong> cancer patients<br />
S. Melkusová, H. Bujdáková, A. Volleková,<br />
Y. Myoken, Y. Mikami<br />
(Bratislava, SK; Hiroshima, Chiba, JP)<br />
P515 Evaluation <strong>of</strong> a colorimetric antifungal<br />
susceptibility test by 2,3-diphenyl-5-thienyl-<br />
(2)-tetrazolium chloride<br />
C. Chang, J. Shin, J.-C. Choi, E.Y. Lee<br />
(Busan, KOR)<br />
www.escmid.org/eccmid2004<br />
page 69
Change language